Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved publishing date : 2021 - 09 - 15 save search
FDA Approves Tissue-Based NGS Companion Diagnostic for Takeda's Targeted Therapy for NSCLC Patients with EGFR Exon20 Insertion Mutations
Published: 2021-09-15 (Crawled : 23:00) - prnewswire.com
TMO | News | $541.52 -1.05% 0.61% 2.1M
|
Health Technology
|
| O: -0.15%
H: 0.12%
C: -0.3%
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.41%
H: 1.11%
C: 0.76%
fda therapy fda approval diagnostic
Takeda’s EXKIVITY™ (mobocertinib) Approved by U.S. FDA as the First Oral Therapy Specifically Designed for Patients with EGFR Exon20 Insertion+ NSCLC
Published: 2021-09-15 (Crawled : 22:00) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.6%
H: 1.01%
C: 0.89%
fda therapy designation
Vicarious Surgical Business Combination Approved; Stock to Begin Trading on the New York Stock Exchange as “RBOT”
Published: 2021-09-15 (Crawled : 21:00) - feed.businesswire.com
BDX | $233.15 0.41% 0.15% 890K
|
Health Technology
|
| O: 0.57%
H: 0.12%
C: -0.19%
Methode Electronics’ Board Approves Dividend
Published: 2021-09-15 (Crawled : 21:00) - globenewswire.com
MEI | $12.3 0.66% 0.0% 300K
|
Electronic Technology
|
| O: 0.35%
H: 1.0%
C: 0.33%
electronics approval
Grupo Aeroportuario del Pacifico Announces Payment Date for Capital Stock Reduction Approved at the Extraordinary Shareholders’ Meeting
Published: 2021-09-15 (Crawled : 21:00) - globenewswire.com
PAC | $155.9 1.04% 0.0% 33K
|
Transportation
|
| O: -0.41%
H: 0.43%
C: 0.17%
U.S. FDA Grants BRUKINSA® (Zanubrutinib) Accelerated Approval in Relapsed or Refractory Marginal Zone Lymphoma
Published: 2021-09-15 (Crawled : 12:00) - biospace.com/
BGNE | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: 2.2%
H: 1.82%
C: -0.44%
fda brukinsa approval granted grant
BridgeBio Pharma Receives FDA Fast Track Designation for Investigational Therapy for the Treatment of Limb-girdle Muscular Dystrophy Type 2i (LGMD2i)
Published: 2021-09-15 (Crawled : 12:00) - biospace.com/
BBIO | $24.98 0.0% 2M
|
Health Technology
|
| O: 0.47%
H: 1.06%
C: -1.02%
treatment fda fda fast track fast track therapy fast track designation designation
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.